agilon health (NYSE:AGL) Stock Price Expected to Rise, TD Cowen Analyst Says

agilon health (NYSE:AGLGet Free Report) had its price target upped by analysts at TD Cowen from $3.50 to $6.00 in a report issued on Tuesday,Benzinga reports. The firm presently has a “hold” rating on the stock. TD Cowen’s price objective points to a potential upside of 10.09% from the stock’s previous close.

A number of other equities research analysts have also weighed in on AGL. Robert W. Baird reduced their target price on shares of agilon health from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Tuesday. Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and lifted their price target for the company from $1.75 to $2.25 in a research report on Friday, January 10th. Royal Bank of Canada upped their price target on agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a report on Wednesday, February 26th. Macquarie initiated coverage on shares of agilon health in a research report on Monday, December 16th. They set a “neutral” rating and a $3.00 price target on the stock. Finally, Sanford C. Bernstein raised agilon health from a “market perform” rating to an “outperform” rating and increased their price target for the company from $3.30 to $8.50 in a research report on Tuesday, April 8th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $4.60.

Get Our Latest Stock Analysis on AGL

agilon health Price Performance

agilon health stock opened at $5.45 on Tuesday. The stock’s fifty day moving average price is $4.12 and its two-hundred day moving average price is $3.11. agilon health has a one year low of $1.50 and a one year high of $7.73. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The firm has a market cap of $2.25 billion, a PE ratio of -5.80 and a beta of 0.38.

Hedge Funds Weigh In On agilon health

Several hedge funds and other institutional investors have recently modified their holdings of the company. Oak Thistle LLC bought a new stake in shares of agilon health in the 4th quarter worth approximately $25,000. Ieq Capital LLC purchased a new position in shares of agilon health during the fourth quarter valued at about $26,000. Signaturefd LLC raised its stake in agilon health by 143.0% in the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock worth $27,000 after buying an additional 8,467 shares in the last quarter. Pallas Capital Advisors LLC purchased a new stake in agilon health in the first quarter worth about $66,000. Finally, Humankind Investments LLC bought a new stake in agilon health during the 4th quarter valued at approximately $30,000.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Read More

Analyst Recommendations for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.